IRIDEX Corporation is a worldwide provider of therapeutic based laser systems, delivery devices and consumable instrumentation used to treat eye diseases in ophthalmology and skin conditions in dermatology (also referred to as aesthetics). Its ophthalmology products consist of laser systems, delivery devices and consumable instrumentation, including laser probes and are used in the treatment of serious eye diseases. In addition, the Company�s ophthalmology products are often used in vitrectomy procedures (used to treat proliferative diabetic retinopathy, macular holes, retinal tears and detachments), which are generally performed in the operating room and require a consumable single use intraocular laser probe (EndoProbe) to deliver light to the back of the eye together with other instrumentation. In February 2012, Cutera, Inc. acquired certain assets of the Company's IRIDEX' aesthetic business unit.